Cargando…
Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients
BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are neoplasms leading to death in most cases. Patients with Neurofibromatosis type 1 have an increased risk of developing this malignancy. The metabolites of the inactive prodrug Sulindac, Sulindac Sulfide and Sulindac Sulfone (Exisulind)...
Autores principales: | Frahm, Silke, Kurtz, Andreas, Kluwe, Lan, Farassati, Faris, Friedrich, Reinhard E, Mautner, Victor F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC425591/ https://www.ncbi.nlm.nih.gov/pubmed/15147581 http://dx.doi.org/10.1186/1475-2867-4-4 |
Ejemplares similares
-
Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1
por: Thomas, Laura, et al.
Publicado: (2012) -
Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors
por: Spyra, Melanie, et al.
Publicado: (2011) -
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors
por: Park, Su-Jin, et al.
Publicado: (2013) -
Sensitivity of Malignant Peripheral Nerve Sheath Tumor Cells to TRAIL Is Augmented by Loss of NF1 through Modulation of MYC/MAD and Is Potentiated by Curcumin through Induction of ROS
por: Reuss, David E., et al.
Publicado: (2013) -
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target
por: Farschtschi, Said, et al.
Publicado: (2020)